Connection

ANDREW LEE to Giant Cell Arteritis

This is a "connection" page, showing publications ANDREW LEE has written about Giant Cell Arteritis.
Connection Strength

13.509
  1. Racial differences in stroke, blindness, and mortality among Black versus non-Black patients with giant cell arteritis: an international cohort study. Can J Ophthalmol. 2026 04; 61(2):333-338.
    View in: PubMed
    Score: 0.866
  2. PARACENTRAL ACUTE MIDDLE MACULOPATHY IN GIANT CELL ARTERITIS. Retin Cases Brief Rep. 2024 May 01; 18(3):285-289.
    View in: PubMed
    Score: 0.779
  3. Giant Cell Arteritis Presenting With Pulseless Disease. J Neuroophthalmol. 2024 Sep 01; 44(3):e336-e338.
    View in: PubMed
    Score: 0.733
  4. Neuro-Ophthalmic Manifestations of Giant Cell Arteritis-Myelodysplastic Subtype. J Neuroophthalmol. 2024 Mar 01; 44(1):e58-e59.
    View in: PubMed
    Score: 0.711
  5. Large-Vessel Vasculitis in Ophthalmology: Giant Cell Arteritis and Takayasu Arteritis. Asia Pac J Ophthalmol (Phila). 2022 Mar-Apr 01; 11(2):177-183.
    View in: PubMed
    Score: 0.670
  6. Dry Nonproductive Cough as the Presenting Symptom of Giant Cell Arteritis. J Neuroophthalmol. 2021 Dec 01; 41(4):e746-e748.
    View in: PubMed
    Score: 0.659
  7. Reply to Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis? J Neuroophthalmol. 2022 06 01; 42(2):e535-e536.
    View in: PubMed
    Score: 0.654
  8. The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis. J Neuroophthalmol. 2021 Sep 01; 41(3):342-350.
    View in: PubMed
    Score: 0.648
  9. Calciphylaxis a Giant Cell Arteritis Mimic: A Case Report and Review of the Literature. J Neuroophthalmol. 2022 03 01; 42(1):e362-e366.
    View in: PubMed
    Score: 0.646
  10. Bilateral Scalp Necrosis in Giant Cell Arteritis. J Neuroophthalmol. 2021 03 01; 41(1):e125-e127.
    View in: PubMed
    Score: 0.625
  11. Perineural Optic Nerve Enhancement in Giant Cell Arteritis: A Case Report and Review of the Literature. J Neuroophthalmol. 2021 03 01; 41(1):e42-e45.
    View in: PubMed
    Score: 0.625
  12. Arteritic Orbital Ischemia Producing Afferent and Efferent Pupillary Defects. J Neuroophthalmol. 2020 12; 40(4):530-532.
    View in: PubMed
    Score: 0.615
  13. Internuclear Ophthalmoplegia as the Presenting Sign of Giant Cell Arteritis. J Neuroophthalmol. 2020 03; 40(1):92-94.
    View in: PubMed
    Score: 0.584
  14. The "Bone Dry" Temporal Artery Biopsy Surgical Field in Giant Cell Arteritis. Ophthalmic Plast Reconstr Surg. 2020 Jan/Feb; 36(1):e26.
    View in: PubMed
    Score: 0.577
  15. Giant cell arteritis relapse presenting as idiopathic orbital inflammation. Can J Ophthalmol. 2020 02; 55(1):e36-e39.
    View in: PubMed
    Score: 0.558
  16. Chronic myelomonocytic leukemia-related vasculitis mimicking giant cell arteritis. Can J Ophthalmol. 2019 06; 54(3):e140-e145.
    View in: PubMed
    Score: 0.534
  17. Vestibulocochlear symptoms as the initial presentation of giant cell arteritis. Can J Ophthalmol. 2019 02; 54(1):e1-e3.
    View in: PubMed
    Score: 0.518
  18. Apical Orbital Aspergillosis Complicating Giant Cell Arteritis. J Neuroophthalmol. 2016 06; 36(2):159-63.
    View in: PubMed
    Score: 0.450
  19. Treatment of giant cell arteritis. Curr Opin Ophthalmol. 2015 Nov; 26(6):469-75.
    View in: PubMed
    Score: 0.432
  20. Neuro-ophthalmic challenges and multi-morbidity in vasculitis among the older adults. Expert Rev Clin Immunol. 2024 07; 20(7):781-791.
    View in: PubMed
    Score: 0.194
  21. Can Ultrasound Replace Temporal Artery Biopsy for Diagnosing Giant Cell Arteritis? J Neuroophthalmol. 2024 Jun 01; 44(2):273-279.
    View in: PubMed
    Score: 0.194
  22. Unilateral temporal artery biopsy. Ophthalmology. 2003 Nov; 110(11):2263; author reply 2263-4.
    View in: PubMed
    Score: 0.188
  23. Paracentral Acute Middle Maculopathy as the Presenting Manifestation of Giant Cell Arteritis. J Neuroophthalmol. 2023 12 01; 43(4):e188-e191.
    View in: PubMed
    Score: 0.167
  24. Giant cell arteritis. Ophthalmology. 2002 Feb; 109(2):220.
    View in: PubMed
    Score: 0.167
  25. Giant Cell Arteritis Presenting as Central Retinal Artery Occlusion and Optic Perineuritis: The Importance of Contrast MRI of the Orbit. J Neuroophthalmol. 2023 12 01; 43(4):e105-e106.
    View in: PubMed
    Score: 0.165
  26. Infectious keratitis as the presenting sign of giant cell arteritis. Can J Ophthalmol. 2020 10; 55(5):e182-e185.
    View in: PubMed
    Score: 0.148
  27. Retrospective, Multicenter Comparison of the Clinical Presentation of Patients Presenting With Diplopia From Giant Cell Arteritis vs Other Causes. J Neuroophthalmol. 2019 Mar; 39(1):8-13.
    View in: PubMed
    Score: 0.136
  28. Pathologic Markers Determining Prognosis in Patients With Treated or Healing Giant Cell Arteritis. Am J Ophthalmol. 2018 09; 193:45-53.
    View in: PubMed
    Score: 0.129
  29. Statin or nonsteroidal anti-inflammatory drug use is associated with lower erythrocyte sedimentation rate in patients with giant cell arteritis. J Neuroophthalmol. 2011 Jun; 31(2):135-8.
    View in: PubMed
    Score: 0.080
  30. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006 Oct; 113(10):1842-5.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.